A-211 - Toward Safe Discontinuation of Immunotherapy in Melanoma: A Multimodal Predictive Model for Relapse Risk

EJC Skin Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles